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Long-term complications of critical illness include intensive care unit (ICU)-acquired weakness and neuropsychiatric 
disease. Immobilisation secondary to sedation might potentiate these problems. Critical illness can last from hours to months, 
depending on the underlying pathophysiology and response to treatment. It carries high morbidity and mortality rates, and 
the associated care is a major determinant of healthcare costs. The evolution of intensive care medicine and integrated team 
management has greatly improved the survival of critically ill patients. In view of the high costs associated with ICU, every 
attempt should continue to be made to prevent complications and appropriately treat the primary underlying pathophysiology 
to minimize length of stay in ICU. There are common complications particularly associated with a prolonged ICU stay, 
including deconditioning, muscle weakness, dyspnoea, depression and anxiety, and reduced health-related quality of life. 
Chronic critical illness is associated with prolonged immobility and intensive care unit (ICU) stay and accounts for 5–10% 
of ICU stays, a proportion that appears to beincreasing . Because of these detrimental sequelae of long-term bed rest, there is 
a need for rehabilitation throughout the critical illness and thereafter , to address these effects. The amount of rehabilitation 
rehabilitation performed in ICUs is often inadequate,
A strategy for whole-body rehabilitation-consisting of interruption of sedation and physical and occupational therapy in the 
earliest days of critical illness-was safe and well tolerated, and resulted in better functional outcomes at hospital discharge, a shorter 
duration of delirium, and more ventilator-free days compared with standard care.
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The nutritional policy in acute severe pancreatitis changed dramatically in the last two decades. After years of recommendations 
for nihil per os combined with total parenteral nutrition, the policy moved to enteral nutrition delivered by jejunostomy combined 
with total parenteral nutrition, than changed to only (if possible) enteral nutrition. Than enteral nutrition by nasojejunal tube was 
advocated. Lately intragastric nutrition in acute severe pancreatitis is under scrutiny. 
The “classical” recommendation nihil per os aimed the pancreatic rest. Meanwhile the caloric needs should be delivered by total 
parenteral nutrition. Fasting has a lot of deleterious consequences: villous atrophy, decreased splanhnic blood flow, loss of epithelial 
tight junctions, decreased secretion of bile salts and IgA, decreased gut associated lymphoid tissue(GALT), bacterial overgrowth 
and bacterial translocation. The impaired GALT alters the macrophage priming, promotes the release of cytokines, free oxygen 
species and arahidonic acid metabolits, all of them resulting in enhanced inflammatory reaction and systemic inflammatory 
response syndrome (1,4,6).
By contrast, enteral nutrition preserves the integrity and the barrier function of intestinal epithelium, enhances blood 
flow, avoids bacterial overgrowth and bacterial epithelial adhesion and prevents bacterial translocation. It is important to 
stress that infection of pancreatic necrosis is due to enteral bacteria (1,4,6). Thus, enteral nutrition is not only a support 
intervention, but a therapeutic one because it may directly influence the evolution of the disease by preventing infection of 
necrotic tissue. It also promotes bowel movements, shortening the duration of paralitic ileus and decreasing intra-abdominal 
pressure. 
Taking into account that 65% of total immune tissues and 80% of immunoglobulin producing tissues belong to the digestive 
tract (gut-associated lymphoid tissue –GALT and mucosal-associated lymphoid tissue –MALT), enteral nutrition has an important 
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effect upon the local and systemic immune response during acute severe pancreatitis. In conclusion, fasting promotes inflammation 
and enteral nutrition promotes appropriate immune function.
Several studies and meta-analysis investigated different parameters (infection rate, morbidity, mortality, rate of surgery, ICU- 
and hospital length-of-stay, costs) in patients with acute pancreatitis comparing enteral versus parenteral nutrition (1,4,8,10). The 
last (2008) Cochrane meta-analysis showed that rates of mortality, hospital length-of-stay, local or systemic infections and of other 
complications favor enteral nutrition (19). Parameters of immune response also favor enteral nutrition, which results in lower rates 
of SIRS, sepsis, multiple organ dysfunction syndrome and mortality.
All these evidences translated into guideline recommendations of the European Society of Enteral and Parenteral Nutrition (7). 
Whenever possible in acute severe pancreatitis enteral nutrition should be used (grade A). If needed, parenteral nutrition may be 
associated to support energy and nutrients requirements. Whenever possible, the oral route should be used, if not, the alternative 
is endoscopically placed naso-jejunal feeding. Feeding jejunostomy may be performed during surgery. Standard enteral formula 
are well tolerated. 
Today a consensus has been reached considering early enteral nutrition as standard of care in acute severe pancreatitis due to 
promotion of appropriate immune response, shortening and improvement of disease evolution, decreased infection and surgery rates 
and diminished costs. However, despite knowledge and commitment, the application of these principles into the daily practice is not 
an easy task. Enteral nutrition in acute severe pancreatitis is still associated with many questions, which are looking for answers.
Who needs nutritional support?
In mild/moderately severe acute pancreatitis the is no need for nutritional support due to the rapid resolution of the disease. 
Fating is still recommended for about 48 hours. By contrast, in acute severe pancreatitis early enteral nutrition is crucial for the 
course of the disease. But early recognition of the severe form is sometimes difficult and clinical, laboratory parameters or scores 
predict with variable accuracy the severity of the disease.
Which is the best route for enteral nutrition?
The degree of pancreatic stimulation depends upon the route of feeding delivery. Oral feeding is associated with the highest 
pancreatic secretion due to the cephalic phase (smell, taste) – resulting in the fasting recommendation. The lowest is associated 
with deep jejunal feeding, resulting in jejunostomy feeding. But the tendency to avoid surgery in acute severe pancreatitis precluded 
jejunostomy and promoted the endoscopically placed nas-jejunal tube as standard route. Double lumen tubes are recommended 
(the jejunal lumen for feeding and the gastric one for decompression). In fact, a lot of difficulties are connected with the use of the 
naso-jejunal tube (frequent duodenal obstruction due to enlargement of the pancreatic head, frequent displacement into stomach, 
need for a very experienced endoscopist). Lately naso-gastric tube feeding was investigated in acute severe pancreatitis (17,20,21). 
The results are encouraging demonstrating not only that disease evolution is not worse, but even shorten. But also this route is 
associated with difficulties (delayed gastric emptying due to duodenal obstruction and paralitic ileus, risk of regurgitation and 
aspiration). 
How early is early?
All advantages of enteral nutrition may be achived with early, but not with late enteral feeding. But how early is early in patients 
with delayed gastric emptying and ileus? Some favor the introduction of enteral nutrition in the first 72 hours (16), others in the 
first 6 hours (17). Guidelines recommend as early as possible, in the moment it is tolerated. The tolerance should be individually 
evaluated due to the large interpersonal variability.
How to deal with digestive intolerance? How to achieve the targeted amount?
Introduction of enteral feeding should be gradual. The starting rate is 15-20ml/hour and it is increased progressively every 
24-48 hours until the total amount of 25kcal/kg/day is achieved. Every 3-4 hours a check of residual volume should be performed, 
because it may signal the retrograde (stomach) tube displacement. The actual recommendations promote continuous delivery 24 
hours/day.
What formula should be used?
Nutrients stimulate the exocrine pancreatic secretion to different degrees, lipids most and carbohydrates least. ESPEN 
recommendations include semielemental (small peptides) or elemental (aminoacids) with low content in long-chain fatty acids 
(grade A). Standard formulas may be used as well. Carbohydrates administration should be accompanied by insulin in order to 
achieve normoglycemia, a difficult goal in acute severe pancreatitis.
Is there a role for TPN? 
In mild/moderate acute pancreatitis parenteral nutrition is contraindicated because it may worsen the evolution. In acute 
severe pancreatitis parenteral nutrition may be used when access to/amount of enteral feeding is impossible/inappropiate. Early 
(the first 48-72 hours) parenteral nutrition is contraindicated because it may aggravate the evolution. It may be introduced after 
5 days, when failure of access or proper amount of enteral nutrition was documented.
Is enteral nutrition supportive or therapeutical intervention?
The patient with acute severe pancreatitis has intense hypercatabolism. Nutritional support doesn’t aim to convert catabolism 
to anabolism, but to prevent energetic exhaustion and to preserve the visceral mass. The multiple advantages of enteral nutrition 
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displace parenteral nutrition, which dominated for decades the scene of nutrition in acute severe pancreatitis. The capacity of 
enteral nutrition to influence the acute phase response, the systemic inflammatory reaction and the infection rate recommend it 
as a therapeutical intervention promoting enhanced recovery.
In conclusion, enteral nutrition in severe acute pancreatitis is not an easy task and needs a lot of commitment and dedication. 
But, despite difficulties its early and “obstinate” application may favorably influence the evolution of the disease.
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Anemia is a common and early condition in critically ill patients. 29% patients have Hb < 10g% at ICU admission (1). 95% 
patients have anemia in the 3rd ICU day (2). We studied the incidence of anemia in 132 critically ill patients with long ICU stay 
(>7 days) and found it presence in 110 (83.33%) patients at ICU admission and in 126 (95.45%) patients at ICU discharge (3). 
Causes of acquired anemia in intensive care patients are blood loss due to surgery, trauma, gastrointestinal bleeding or medical 
procedures (mainly phlebotomy), hemodilution, decreased red blood cell production or increased distruction and others (4). 
Phlebothomy may result in 30-70ml blood withdrawal/day (1,2). In critically ill patients an increase of 3,5ml/day withdrawn blood 
doubles the risk of transfusion (5). The amount of blood withdrawn by phlebotomy decreases over time during ICU stay, mainly 
due to decreased number of ABG (5). 
The critical illness is frequently associated with inflammatory status. The proinflammatory cytokines (TNFα, IL-1, IL-6) 
result in failure of circulating EPO to appropriately increase in response to Hb reduction (relative EPO deficiency), inhibition of 
erythrocyte production (relative EPO resistance) and decreased iron availability (6,7,8). Corwin terms this status as anemia of 
critical illness. 
Iron metabolism is severely altered in during critical illness. The main features are decreased iron availability for erythropoesis 
and increased iron storage (9). Markers of iron metabolism alterations during inflammation are decreased serum Fe, decreased 
